171 related articles for article (PubMed ID: 25874769)
1. Erythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in Xenografts of HeLa Cells to Promote Their Destruction.
Yasuda Y; Fujita M; Koike E; Obata K; Shiota M; Kotani Y; Musha T; Tsuji-Kawahara S; Satou T; Masuda S; Okano J; Yamasaki H; Okumoto K; Uesugi T; Nakao S; Hoshiai H; Mandai M
PLoS One; 2015; 10(4):e0122458. PubMed ID: 25874769
[TBL] [Abstract][Full Text] [Related]
2. Significance of Erythropoietin Receptor Antagonist EMP9 in Cancers.
Yasuda Y; Fujita M
Vitam Horm; 2017; 105():297-310. PubMed ID: 28629523
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
4. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
Lopez TV; Lappin TR; Maxwell P; Shi Z; Lopez-Marure R; Aguilar C; Rocha-Zavaleta L
Int J Cancer; 2011 Dec; 129(11):2566-76. PubMed ID: 21442620
[TBL] [Abstract][Full Text] [Related]
5. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
[TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways.
Um M; Lodish HF
J Biol Chem; 2006 Mar; 281(9):5648-56. PubMed ID: 16407271
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
8. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-mediated JAK2/STAT5 signalling pathway in the TF-1/ Epo human leukemia cell line.
Li J; Wei Q; Zuo GW; Xia J; You ZM; Li CL; Chen DL
Asian Pac J Cancer Prev; 2014; 15(6):2453-9. PubMed ID: 24761846
[TBL] [Abstract][Full Text] [Related]
11. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
12. Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis.
Chang HC; Huang DY; Wu MS; Chu CL; Tzeng SJ; Lin WW
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):687-696. PubMed ID: 28131718
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
Ogilvie M; Yu X; Nicolas-Metral V; Pulido SM; Liu C; Ruegg UT; Noguchi CT
J Biol Chem; 2000 Dec; 275(50):39754-61. PubMed ID: 10995753
[TBL] [Abstract][Full Text] [Related]
15. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
Chan KK; Matchett KB; Coulter JA; Yuen HF; McCrudden CM; Zhang SD; Irwin GW; Davidson MA; Rülicke T; Schober S; Hengst L; Jaekel H; Platt-Higgins A; Rudland PS; Mills KI; Maxwell P; El-Tanani M; Lappin TR
Oncotarget; 2017 Jun; 8(24):38251-38263. PubMed ID: 28418910
[TBL] [Abstract][Full Text] [Related]
17. STAT5 as a Key Protein of Erythropoietin Signalization.
Tóthová Z; Tomc J; Debeljak N; Solár P
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281163
[TBL] [Abstract][Full Text] [Related]
18. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
19. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
[TBL] [Abstract][Full Text] [Related]
20. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]